Related Experiment Video
Updated: May 22, 2026

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron
Published on: February 23, 2024
[Iron therapy: Indications, limitations and modality]
J-B Arlet1, J Pouchot, S Lasocki
1Service de médecine interne, centre de référence des syndromes drépanocytaires majeurs, université Paris-Descartes, Sorbonne Paris-Cité, hôpital européen Georges-Pompidou, Assistance publique-Hôpitaux de Paris, 20, rue Leblanc, 75908 Paris cedex 15, France. jean-benoit.arlet@egp.aphp.fr
Abstract:
During the past 10 years, the knowledge of iron metabolism has been revolutionized by the discovery of the main regulatory hormone of body iron: hepcidin. Meanwhile, new formulations of intravenous iron have been developed and are already or readily available. In this article, we review the recent pathophysiological mechanisms underlying anemia of chronic disease or due to iron deficiency. We describe the various treatment modalities of iron deficiency anemia using oral or intravenous route and the emerging indications of treatment with iron. Finally, we discuss the situations in which iron supplementation may be harmful.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Rheumatic Heart Disease III: Medical Management
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Drug Therapy
Antianxiety Medications
Myocarditis III: Medical Management